Work

Association of intravenous (IV) and intramuscular (IM) pegaspargase (PEG) administration with rate of adverse events (AE) in standard risk (SR) Acute Lymphoblastic Leukemia (ALL) Children’s Oncology Group (COG) trials.

Year: 2015

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2015.33.15_suppl.10035

Authors: Kelly W. Maloney, Anne L. Angiolillo, Reuven J. Schore, Meenakshi Devidas, Xiaomin Lu, Cindy Wang, Alison M. Friedmann, Leonard A. Mattano, Mignon L. Loh, Elizabeth A. Raetz, Linda C. Stork, Naomi J. Winick, Stephen Hunger, William L. Carroll

Institutions: Children's Hospital Colorado, Children's National, University of Florida, Massachusetts General Hospital, University of California, San Francisco, University of Utah, Oregon Health & Science University, The University of Texas Southwestern Medical Center, Children's Hospital of Philadelphia, NYU Langone Health

Language: English

Topic: Acute Lymphoblastic Leukemia research

Subfield: Public Health, Environmental and Occupational Health

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2936672017

Cites:

Cited by: 4

Related to: 10